Mayne Pharma Ventures Pty Ltd Inhibitor Therapeutics, Inc. (INTI) insider trading activity

INTI Quotes by TradingView

Mayne Pharma Ventures Pty LTD is > 10% Shareholder of Inhibitor Therapeutics, Inc.. Currently has a direct ownership of 204 Million shares of INTI, which is worth approximately $16.3 Million. The most recent transaction as insider was on Jan 15, 2021, when has been sold 2,240,488 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 204M
0% 3M change
0% 12M change
Total Value Held $16.3 Million

Mayne Pharma Ventures Pty Ltd Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 15 2021
BUY
Other acquisition or disposition
-
2,240,488 Added 1.09%
204,083,227 Common Stock
MPV

Mayne Pharma Ventures Pty LTD

> 10% Shareholder
Salisbury South, Sa, C3

Track Institutional and Insider Activities on INTI

Follow Inhibitor Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INTI shares.

Notify only if

Insider Trading

Get notified when an Inhibitor Therapeutics, Inc. insider buys or sells INTI shares.

Notify only if

News

Receive news related to Inhibitor Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on INTI